PubMed · 12937052
Neonatologists are using much less dexamethasone.
Abstract
Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality fell from 21% to 15% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
E S Shinwell, M Karplus, D Bader, S Dollberg, I Gur, Z Weintraub, S Arnon, E Gottfreid, A Zaritsky, I R Makhoul, D Reich, L Sirota, I Berger, A Kogan, S Yurman, M Goldberg, D Kohelet. 2003. Neonatologists are using much less dexamethasone.. https://doi.org/10.1136/fn.88.5.f432
Cite the original work for its findings. Save a collection to share your selection of sources.